I t is a pleasure to introduce this series of review articles on affective disorders in The Canadian Journal of Psychiatry. As you may already know from the February editorial by Dr Quentin Rae-Grant, Editor-in-Chief (1) , this year the Journal has started a tradition of publishing such articles to keep up with the accelerated pace of knowledge. These articles have been written by experts on the topic exclusively for the readers of the Journal. In this issue, you will find review articles on the epidemiology of disordered mood and the genetics of bipolar disorders.
The selection of specific topics has been an interesting task. It was certainly tempting to select some of the alluring topics that have heavily coloured our field for the past 30 years-psychopharmacology, neuropharmacology, neurochemistry-but excellent update articles and chapters about these topics are available in other journals for a hungry review reader. Thus the choice fell instead on the topics that have been and will remain the pillars of the field of mood disorders.
How does one determine what the foundation stones are? For 2 decades I was the junior member of an international research group on affective disorders that included most of the leaders in the field. The group met regularly to discuss all the new, exciting findings and developments in biological and psychosocial domains. Two points always became painfully clear. First, the obvious: the field had become incredibly rich with information. Second, clear consensus emerged only on a few points: that mood disorders are very common in the population, frequently run in families, tend to recur, and can usually be successfully treated. Beyond these issues, the debating participants parted in their views, often dramatically. In this issue of the Journal, we are fortunate to present exquisite reviews on the first 2 topics of consensus: prevalence in the population and clustering in families.
It is obviously very important to determine how many persons with abnormal moods there are in the population; practical decisions regarding best care, preventative measures in public health, and the correct interpretation of research findings rely on this information. Dr Roger Bland, the leading Canadian expert in epidemiology, has reviewed studies using standardized methodology and classification systems to enable comparisons between locations and cultures. His article (2) reflects well the major advances in epidemiological thinking that have taken place during the last 15 years. Psychiatric epidemiology remains hampered by the lack of valid, lasting diagnoses, but even with imperfect devices, consistent findings have emerged.
First, affective disorders are very common in the populations of all countries studied. The high prevalence rates of affective disorders demonstrate that they present a major public health problem. Second, to make things worse, the high rates of major depression appear to be increasing, and both the unipolar and bipolar disorders appear to be occurring at younger ages. In some cohorts, the increased rates and earlier onset appeared in those born after the Second World War; in others, these changes were observed even earlier. The combination of such observations makes one wonder: Have we perhaps entered the age of misery and melancholy? Third, even with modern methodology, findings vary markedly from study to study and from place to place. Fourth, women suffer from major depressive disorders more often than men. Finally, these worrisome developments are complicated by other contemporary features of affective disorders: long duration, high likelihood of recurrence, long delays in treatment seeking, deficiencies in diagnosing, and inadequate treatment and follow-up. Excellent reviews, being state-of-the-art statements, often stimulate queries. While both reviewers carefully refrained from conjectures, speculations and questions are permissible in an editorial and are important for the field. The first question relates to epidemiology. Why might the rate of affective disorders be on the increase? It has been pointed out that the major jump took place in the 1970s, almost surely an artifact of the change of diagnostic fashion (3, 4) after the successful introduction of long-term treatments. But what about the rest of the increase? Speculations have revolved around greater stress of more industrialized living, fragmentation of social structures and softening of social supports, greater accessibility of care, lesser stigma, and earlier treatments, as well as more far-fetched ideas. Much has been conjectured about this phenomenon, with no firm conclusion as yet.
To interpret properly the reported increases in the population, epidemiological studies will need to measure concomitantly most major psychiatric disorders. Otherwise increases and decreases in individual diagnoses are difficult to interpret meaningfully and to separate from the shifts from one diagnosis to another. Another puzzling question: Why, even after the employment of modern methodology, do we continue to see such tremendous variation in findings? The epidemiology of affective disorders has always been characterized by a great diversity of findings from location to location and from one time period to another. That a similar spread lingers even when the most modern methodology is introduced may indicate that these marked differences are not just a usual error of measurement but rather a true finding compelling an interpretation. One could expect some variation due to different sociocultural factors and disparately trained observers, but deviations of this size (for example, prevalence rate for major depression ranging from 1.5% to 19%) raise the question of whether we need to adjust our thinking about mood disorders as traditional diagnostic entities in the form we inherited from Griesinger, Virchow, and Kraepelin. Should we perhaps consider approaching them more as variable dysfunctions of a dynamic, complex system of mood regulation?
The third question: Do women really suffer from affective disorders that much more often than men, and if so, why? The greater hormonal complexity probably plays a major role in these processes. Nevertheless, the actual differences are probably grossly exaggerated because women are more articulate about their mood states and are less resistant to reaching out for help with depression than men.
The second review article (5), on the genetics of bipolar disorders, has been contributed by Dr Martin Alda, an accomplished researcher in psychiatric genetics. Genetics has been one of the hottest issues in psychiatric research in recent years. With rapid technical advances during the past decade and the resulting breakthrough discoveries, molecular genetics is on the move. Bipolar maladies, with the highest degree of genetic contribution and less heterogeneity than unipolar illnesses, are the obvious top target. There is currently tremendous excitement about this search. It stems from a justified expectation that, within the next 3 to 5 years, major advances will take place and clarify the genetic contribution to bipolar disorders. These important breakthroughs will certainly have major implications for the understanding and possibly also for the treatment of affective disorders.
Dr Alda summarizes what is currently known about efforts to establish the genetic basis of bipolar illness and to elucidate the nature of its genetic predisposition. His review reflects the evolution of the genetics of bipolar disorder from family studies describing familial clustering, through adoption and twin studies, which helped disentangle the effects of nature from nurture, to the present era of molecular genetics.
He outlines the major methodological difficulties, such as the unknown mode of transmission, that reflect the obstacles troubling heterogeneity and the unclear phenotypical manifestations. He stresses that despite the methodological difficulties inherent in the study of such complex disorders, the recent molecular genetic investigations have already made important advances. The completed association and linkage studies in bipolar disorders are comprehensively reviewed. Dr Alda points to converging, promising and, more importantly, replicated findings on chromosomes 18 and 21. He clarifies that the present findings indicate bipolar disorder to be a heterogeneous condition characterized by a complex relationship between the genetic susceptibility and the clinical presentation.
This review of the genetics of bipolar illness generates a number of questions: Could the convergence of findings on chromosome 18 become a replay of the earlier, first promising and then frustrating story of chromosome 11, or are we perhaps closer this time? Will the understanding of genetic contribution open up a new era of psychobiological research and lead to our comprehension of the role of environment and of the interactions between these elements? Once we have the malefactor, what shall we do about it? Can we come up with some useful preventive measures that can bypass whatever drawback these genes impose, and further ahead, can we replace, repair, or regenerate what is different? Finally, is it desirable to do so? Subsequent review articles in this series (6,7) will cover some interesting and important but insufficiently explored areas of affective disorders and span from cutting-edge research to the management of the most clinically challenging patients.
